PHILADELPHIA CHROMOSOME POSITIVE (PH+) ACUTE-LEUKEMIA - MORPHOLOGY, CLINICAL FEATURES, AND SURVIVAL OF 9 PATIENTS

被引：0
作者：
PETERSON, LC [1 ]
BLOOMFIELD, CD [1 ]
BRUNNING, RD [1 ]
机构：
[1] UNIV MINNESOTA,SCH MED,MINNEAPOLIS,MN 55455
来源：
LABORATORY INVESTIGATION | 1976年 / 34卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：346 / 347
页数：2
相关论文
共 50 条
  • [21] PHILADELPHIA CHROMOSOME-POSITIVE ACUTE-LEUKEMIA - A NEW BCR AND A MODEL OF RECOMBINATION
    CHEN, SJ
    CHEN, Z
    LARSEN, CJ
    BERGER, R
    [J]. M S-MEDECINE SCIENCES, 1989, 5 (05): : 282 - 283
  • [22] REARRANGEMENT OF THE BREAKPOINT CLUSTER REGION IN PHILADELPHIA-CHROMOSOME POSITIVE ACUTE-LEUKEMIA
    TAKAHASHI, I
    SEKITO, N
    TAKEUCHI, M
    OSADA, K
    MATSUZAKI, T
    FUKUDA, S
    LAI, MY
    UCHIDA, K
    KIMURA, I
    MIYAMOTO, K
    KITAJIMA, K
    SANADA, H
    [J]. ACTA MEDICA OKAYAMA, 1988, 42 (02) : 117 - 120
  • [23] Characteristics of Philadelphia-positive acute lymphocytic leukemia (Ph+ ALL) in the elderly.
    Coso, D
    Cazin, B
    Thomas, X
    Boiron, JM
    Huguet, F
    Zérazhi, H
    Vernant, JP
    Dombret, H
    Bilhou-Nabera, C
    Charrin, C
    Boucheix, C
    Sebban, C
    Lhéritier, V
    Delannoy, A
    Fière, D
    [J]. BLOOD, 2001, 98 (11) : 319A - 319A
  • [24] Outcome of Patients with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) with Relapse After Tyrosine Kinase Inhibitor (TKI) Therapy
    Lee, Hun Ju
    O'Brien, Susan
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Faderl, Stefan
    Koller, Charles
    Konopleva, Marina
    Verstovsek, Srdan
    Kadia, Tapan
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Wierda, William G.
    Burger, Jan A.
    Thomas, Deborah A.
    Cortes, Jorge E.
    [J]. BLOOD, 2011, 118 (21) : 659 - 659
  • [25] Potential value of autologous bone marrow transplantation for Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) in childhood.
    Baruchel, A
    Auclerc, MF
    Bordigoni, P
    Lamagnere, JP
    Leblanc, T
    Landman, J
    Esperou, H
    Stephan, JL
    Comu, G
    Sommelet, D
    Leverger, G
    Schaison, G
    [J]. BLOOD, 1996, 88 (10) : 489 - 489
  • [26] In vitro drug resistance to imatinib and mutation of ABL gene in childhood Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia
    Kawaguchi, H
    Taketani, T
    Hongo, T
    Park, MJ
    Koh, K
    Ida, K
    Kobayashi, M
    Takita, J
    Taki, T
    Yoshino, H
    Bessho, F
    Hayashi, Y
    [J]. LEUKEMIA & LYMPHOMA, 2005, 46 (02) : 273 - 276
  • [27] PHILADELPHIA CHROMOSOME IN ACUTE-LEUKEMIA - CASE-REPORT
    SECKERWALKER, LM
    HARDY, JD
    [J]. CANCER, 1976, 38 (04) : 1619 - 1624
  • [28] Impact of complete molecular response (CMR) on survival in patients with Philadelphia chromosome positive (Ph plus ) acute lymphoblastic leukemia (ALL).
    Short, Nicholas James
    Jabbour, Elias
    Cortes, Jorge E.
    Garris, Rebecca
    O'Brien, Susan Mary
    Patel, Keyur
    Sasaki, Koji
    Issa, Ghayas C.
    Garcia-Manero, Guillermo
    Thomas, Deborah A.
    Kantarjian, Hagop M.
    Ravandi, Farhad
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] PHILADELPHIA CHROMOSOME (PH1) IN ADULTS PRESENTING WITH ACUTE-LEUKEMIA - COMPARISON OF PH1 + AND PH1- PATIENTS
    BLOOMFIELD, CD
    PETERSON, LC
    YUNIS, JJ
    BRUNNING, RD
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1977, 36 (03) : 347 - 358
  • [30] Population pharmacokinetics of imatinib in patients with newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in chronic phase.
    Bin, P
    Schmidli, H
    Riviere, GJ
    Racine, A
    Capdeville, R
    [J]. BLOOD, 2002, 100 (11) : 784A - 784A
12345